Tenon Medical (NASDAQ:TNON) Stock Set to Reverse Split on Monday, August 10th

Posted by on Aug 6th, 2026

Shares of Tenon Medical, Inc. (NASDAQ:TNON – Free Report) are scheduled to reverse split on the morning of Monday, August 10th. The 1-35 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, August 9th.

Tenon Medical Trading Down 12.4%

NASDAQ:TNON traded down $0.02 on Thursday, hitting $0.17. 1,838,470 shares of the company’s stock traded hands, compared to its average volume of 3,512,266. The company has a market cap of $1.99 million, a PE ratio of -0.13 and a beta of 1.39. Tenon Medical has a 1 year low of $0.16 and a 1 year high of $1.74. The firm has a 50-day moving average price of $0.38 and a 200-day moving average price of $0.65.

Tenon Medical (NASDAQ:TNON – Get Free Report) last issued its earnings results on Tuesday, May 12th. The company reported ($0.31) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.30) by ($0.01). The business had revenue of $1.38 million during the quarter, compared to analyst estimates of $1.30 million. Tenon Medical had a negative net margin of 270.09% and a negative return on equity of 907.60%.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of Tenon Medical in a research note on Friday, July 17th. Alliance Global Partners reissued a “buy” rating on shares of Tenon Medical in a research note on Wednesday, May 13th. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold”.

View Our Latest Analysis on Tenon Medical

Institutional Trading of Tenon Medical

Several large investors have recently made changes to their positions in the stock. Jane Street Group LLC acquired a new position in Tenon Medical in the first quarter worth about $29,000. Geode Capital Management LLC boosted its holdings in Tenon Medical by 34.6% during the fourth quarter. Geode Capital Management LLC now owns 66,640 shares of the company’s stock valued at $63,000 after purchasing an additional 17,137 shares in the last quarter. Finally, DRW Securities LLC bought a new stake in shares of Tenon Medical in the 4th quarter valued at approximately $98,000. Institutional investors own 22.74% of the company’s stock.

Tenon Medical Company Profile

(Get Free Report)

Tenon Medical, Inc is a development-stage medical device company focused on the research, development and commercialization of next-generation surgical biologic adhesives and sealants. The company’s proprietary platform is designed to create tissue-compatible adhesives that can serve as alternatives or complements to traditional sutures and staples, with the goal of improving surgical efficiency, reducing postoperative complications and enhancing patient outcomes.

Tenon Medical’s product pipeline centers on protein-based polymer formulations that cross-link in situ to form a flexible, yet durable, bond with native tissue.

Featured Articles

Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.